US Instruments, Inc.

US Instruments, Inc., a woman-owned small business based in Lanoka Harbor, New Jersey, manufactures and supplies specialized vascular diagnostic medical equipment to the Department of Veterans Affairs as a prime contractor, operating exclusively on the GSA Medical Equipment and Supplies Schedule (FSS-65-II-A) with no subcontract footprint across its 109 recent federal awards.

US Instruments is a for-profit corporation registered in SAM.gov since 2004 that specializes in Parks Medical Electronics flow laboratory units, ankle-brachial index monitors, Doppler ultrasound systems, and plethysmograph devices for non-invasive vascular assessment. The vendor competes under woman-owned small business designations — recurring across the prime portfolio are Woman-Owned Small Business Sole Source and Total Small Business set-asides, though the majority of recent awards carry no set-aside designation. Representative work includes a $72,341.70 delivery order from Veterans Integrated Service Network 21 for SONOVAE vascular diagnostic equipment awarded August 31, 2026, a $114,212.55 order from VISN 9 for three FLO-LAB Model 2100-SX2 units awarded June 30, 2026, and a $36,170.85 delivery order from VISN 4 for a FLO-LAB system awarded August 14, 2026.

Customer concentration is extreme and singular. The top five VISNs (Veterans Integrated Service Networks) account for 40% of recent awards by count but the portfolio spans 22 distinct customer agencies within the VA system. By dollar value, concentration shifts sharply: VISN 12 anchors 77% of combined potential value at $7.6 million across only five awards, while VISN 10, VISN 21, VISN 23, and VISN 9 comprise the remaining high-value set. This divergence signals that US Instruments holds one or two large multiyear delivery arrangements with VISN 12 while sustaining a broad base of smaller, routine orders across the wider VA network.

US Instruments operates exclusively on the GSA Medical Equipment and Supplies Schedule, with 73 task orders carrying $4.1 million in combined potential value. The vendor holds no parent IDIQs, GWACs, or BPAs; all work flows through the GSA Schedule vehicle, which constrains competition to full-and-open federal procurement and precludes teaming with other contractors as a prime.

Activity has declined measurably. The vendor averaged 16 awards per year in 2022, dropped to ten in 2023, four in 2024, then recovered to nine in 2025 and five in 2026 to date. Only three awards (combined potential value $223 thousand) face completion within the next twenty-four months, signaling minimal recompete exposure in the near term. Combined potential value across all 109 awards sits at $12.3 million, with $4.9 million obligated to date (40% draw-down), indicating steady invoicing against delivery orders but a modest overall revenue footprint relative to the award count.

US Instruments has no subcontract relationships in the source data — 100% of awards are prime. The vendor's capability portfolio is narrow and specialized: Parks Medical Electronics vascular diagnostic systems dominate the NAICS and PSC classification, with 84 awards under Surgical and Medical Instrument Manufacturing (NAICS 334510) and 75 under Medical and Surgical Instruments, Equipment, and Supplies (PSC code). This vertical specialization, combined with exclusive reliance on the GSA Schedule vehicle, positions US Instruments as a niche medical equipment supplier to the VA with limited crossover to other civilian or defense agencies and no competitive leverage on multi-agency or large-vehicle programs.